Promote this Nomination
|Company size (employees)||300+|
In 3 bullets, summarize why this company is different from the competition and deserves recognition:
o Applied the ground-breaking Bayesian Estimation theory, developed by mathematicians at the University of Cambridge, and unsupervised machine learning to protect critical information assets and intellectual property via the Enterprise Immune System
o Secured a plethora of high-level clients globally, spanning all industries from retail, telecommunications, and media to transportation, energy, and financial services
o From 2015 to 2016, Darktrace won multiple awards around the world, including the Queen’s Award for Innovation in 2016, ‘Best Security Technology’ at the 2016 Techies, and a gold medal at the 2015 Business Awards
Darktrace is a world-leading cyber-threat defense company. Its multi-award-winning Enterprise Immune System technology automatically detects and responds to emerging threats, powered by machine learning and mathematics developed by specialists from the University of Cambridge. Without using rules or signatures, Darktrace models the ‘pattern of life’ of every device, user and network within an organization, identifying and mitigating cyber-threats before damage is done. Since its foundation in 2013, Darktrace has experienced phenomenal growth, a testament to the global demand for the company’s innovative machine learning technology and its success on the market.
With a 615% year-on-year revenue increase from 2015 to 2016 and a 240% booking increase in the last fiscal year, Darktrace is rapidly expanding its 350+ customer base. Deployed over 1,300 times globally within just three years, the Enterprise Immune System has been adopted by diverse organizations that span all industry verticals. Our customers range from large companies, including T-Mobile and DirecTV, to small and medium enterprises.
Darktrace has become a global leader in an intensely competitive cyber security space. In May 2016, CEO Nicole Eagan accompanied the US Embassy on their official trade mission to Asia, where Darktrace later secured a partnership with Samsung SDS. Darktrace has also recently expanded into India and Latin America. In July, the company gained $65 million in Series C funding from KKR, a private equity pioneer, to drive further global expansion.
Darktrace’s product suite is continuously expanding—immune system defense is now available for SaaS, Cloud, and other virtual environments, as well as for Industrial Control Systems. Darktrace’s dedication to expanding the frontiers of cyber security and looking toward future innovation is best exemplified by its latest product release: Antigena, a ground-breaking new technology that allows networks to automatically self-defend.
Winner of a Business Weekly award for ‘best disruptive technology,’ Darktrace is redefining an industry.